Repligen
RGEN
#2414
Rank
$7.69 B
Marketcap
$136.50
Share price
-0.37%
Change (1 day)
9.74%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of March 2026 : $0.78 Billion USD

According to Repligen 's latest financial reports the company has $0.78 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$0.76 B1.36%
2024-12-31$0.75 B0.8%
2023-12-31$0.75 B20.45%
2022-12-31$0.62 B3.3%
2021-12-31$0.60 B-15.82%
2020-12-31$0.71 B35.75%
2019-12-31$0.52 B172.62%
2018-12-31$0.19 B11.55%
2017-12-31$0.17 B22.56%
2016-12-31$0.14 B97.54%
2015-12-31$71.77 M22.79%
2014-12-31$58.45 M-5.14%
2013-12-31$61.62 M53.85%
2012-12-31$40.05 M
2011-03-31$49.62 M-6.61%
2010-03-31$53.13 M8.75%
2009-03-31$48.85 M-1.86%
2008-03-31$49.78 M120.02%
2007-03-31$22.62 M19.87%
2006-03-31$18.87 M9.68%
2005-03-31$17.2 M23.33%
2004-03-31$13.95 M-10.12%
2003-03-31$15.52 M-25.5%
2002-03-31$20.83 M-12.94%
2001-03-31$23.93 M-29.66%
2000-03-31$34.03 M931.3%
1999-03-31$3.3 M-29.79%
1998-03-31$4.7 M34.29%
1997-03-31$3.5 M-49.28%
1996-03-31$6.9 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
$13.07 B 1,566.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$3.25 B 315.03%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$10.98 B 1,299.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$10.48 B 1,236.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$29.61 M-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$0.79 B 0.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$1.31 B 67.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$0.20 B-73.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.22 B 183.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$0.19 B-75.55%๐Ÿ‡บ๐Ÿ‡ธ USA